Posted in | News | Iron Ore | Potash

BHP Billiton Begins Share Buyback

BHP Billiton is trying to salvage the situation after its Canadian Potash bid fell through. The Chief Executive Officer Marius Kloppers must be disappointed after this third failed proposition. The first two being related to the hostile bid for Rio Tinto and the following iron ore joint venture with Rio Tinto in the Pilbara region of Australia.

Marius Kloppers had already raised loans worth $45 billion in anticipation of the acquisition of the world’s largest fertilizer company. The proposal received great resistance from politicians and investors alike. Eventually the Stephen Harper led government said that the sale would not provide a net benefit to Canada.

Now that the plan has been scrapped for good by the Canadian government the mining company has begun a share buyback. The Melbourne based company has reactivated the $4.2 billion part of its $13 billion share buyback program. Analysts at Morgan Stanley feel that BHP Billiton will spend the next two year buying back shares worth $25 billion.

BHP Billiton has not completely given up on the fertilizer industry and will continue to develop its Jansen potash project in Canada. This would work out to be the world’s largest potash mine in a few years.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 18). BHP Billiton Begins Share Buyback. AZoMining. Retrieved on April 14, 2024 from

  • MLA

    Chai, Cameron. "BHP Billiton Begins Share Buyback". AZoMining. 14 April 2024. <>.

  • Chicago

    Chai, Cameron. "BHP Billiton Begins Share Buyback". AZoMining. (accessed April 14, 2024).

  • Harvard

    Chai, Cameron. 2019. BHP Billiton Begins Share Buyback. AZoMining, viewed 14 April 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.